Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis.

However, there is always a challenge associated with these techniques, similarly in the case of GC/MS, which taps only into the volatile compounds that are present in samples and compromises metabolites that are non-volatile but might be significant, while in LC/MS and the associated addition of sophisticated MS, there are greater chances of acquiring errors and the identification of noise (unwanted particles), along with only the one time use of samples [ 28 ].

also in 2,457 other papers